The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays

Journal of Medical Virology

Volumn 78, Issue 3, 2006, Pages 311-317

  Von Truchsess, Inge ^a   Harris, Barbara ^b   Schätzl, Hermann M ^a   Hackett Jr , John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Genetic diversity; HIV 1; Quantitation; Recombinant

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; BINDING SITE; BIODIVERSITY; CASE REPORT; CHIMERA; DNA PROBE; EVALUATION; FEMALE; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNODOMINANT REGION SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; QUANTITATIVE ASSAY; QUANTITATIVE DIAGNOSIS; RELIABILITY; SEQUENCE ANALYSIS; STRAIN IDENTIFICATION; VIRUS DETECTION; VIRUS LOAD; VIRUS RECOMBINATION;

ADULT; BASE PAIR MISMATCH; FEMALE; GERMANY; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHYLOGENY; REAGENT KITS, DIAGNOSTIC; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33644638644     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20541     Document Type: Article

References (24)

1. Antunes R, Figueiredo S, Bártolo I, Pinheiro M, Rosado L, Soares I, Lourenço H, Taveira N. 2003. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J Clin Microbiol 41:3361-3367.
2. M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 11:1503-1508.
3. Barlow KL, Tatt ID, Cane PA, Pillay D, Clewley JP. 2001. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses 17:467-474.
4. Brunn M, Rokos K, Kücherer C. 1998. Langzeitbeobachtung von Probanden mit bekanntem Zeitpunkt der HIV-Serokonversion Zwischenbericht zur HIV-Serokonverter-Studie des RKI. Epidemiologisches Bulletin 32:228-230.
5. Coffin JM. 1995. HIV-1 population dynamics in vivo: Implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
6. Cornelissen M, Kampinga G, Zorgdrager F, Goudsmit J. 1996. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization. J Virol 70:8209-8212.
7. Delgado E, Thomson MM, Villahermosa ML, Sierra M, Ocampo A, Miralles C, Rodríguez-Pérez R, Diz-Aren J, Ojea-de Castro R, Losada E, Cuevas MT, Vázquez-de Parga E, Carmona R, Pérez-Alvarez L, Medrano L, Cuevas L, Taboada JA, Nájera R. 2002. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 29:536-543.
8. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vézinet F. 1997. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol 71:8893-8898.
9. Descamps D, Apetrei C, Collin G, Damond F, Simon F, Brun-Vézinet F. 1998. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 12:1109-1111.
10. Esteves A, Parreira R, Piedade J, Venenno T, Franco M, Germano de Sousa J, Patrícío L, Brum P, Costa A, Canas-Ferreira WF. 2003. Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses 19:511-517.
11. Geelen S, Lange J, Borleffs J, Wolfs T, Weersink A, Schuurman R. 2003. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: A case of unexpected vertical transmission. AIDS 17:781-782.
12. Harris B, von Truchsess I, Schätzl HM, Devare SG, Hackett J, Jr. 2005. Genomic characterization of a novel HIV Type 1 B/G Intersubtype Recombinant Strain from an injecting drug user in Germany. AIDS Res Hum Retroviruses 21:654-660.
13. Liitsola K, Holm K, Bobkov A, Pokrovsky V, Smolskaya T, Leinikki P, Osmanov S, Salminen M. 2000. An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: Low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res Hum Retroviruses 16:1047-1053.
14. Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG. 2001. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol 39:3122-3128.
15. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J, WHO-UNAIDS Network for HIV Isolation and Characterization. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 29:184-190.
16. Parry JV, Murphy G, Barlow KL, Lewis K, Rogers PA, Belda FJ, Nicoll A, McGarrigle C, Cliffe S, Mortimer PP, Clewley JP. 2001. National surveillance of HIV-1 subtypes for England and Wales: Design, methods, and initial findings. J Acquir Immune Defic Syndr 26:381-388.
17. Pasquier C, Sandres K, Salama G, Fuel J, Izopet J. 1999. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA. J Virol Methods 81:123-129.
18. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
19. Swanson P, Harris BJ, Holzmayer V, Devare SG, Schochetman G, Hackett J, Jr. 2000. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA Quantitative Assay. J Virol Methods 89:97-108.
20. Swanson P, Devare SG, Hackett J, Jr. 2003. Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: Sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 19:625-629.
21. Tatt ID, Barlow KL, Nicoll A, Clewley JP. 2001. The public health significance of HIV-1 subtypes. AIDS 15:S59-S71.
22. Thomson MM, Delgado E, Manjón N, Ocampo A, Villahermosa ML, Marino A, Herrero I, Cuevas MT, Vázquez-de Parga E, Pérez-Álvarez L, Medrano L, Taboada JA, Nájera R, Spanish Group for Antiretroviral Studies in Galicia. 2001. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 15:509-516.
23. Troonen H, Grey H, Michel G. 2002. Multicenter study of the LCx HIV RNA quantitative assay-A new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA. Clin Chem Lab Med 40:698-704.
24. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, Delaporte E. 2000. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 38:3919-3925.